Moderna Inc. (0QF)
FSX
Real-time Data
06:00 AM
Day's Range
164.0852 wk Range
19.26Overview - 0QF - Moderna Inc.
Key Statistics
Valuation
Enterprise Value
57.26B
P/E (Trailing)
‪25.27‬
PEG Ratio
‪-3.36‬
Price / Sales (TTM)
‪31.02‬
Price / Book
‪11.62‬
EV / EBITDA
‪-29.73‬
Profitability
Gross Margin
‪34.96%‬
Profit Margin
‪-141.42%‬
Operating Margin
‪-557.93%‬
Return on Assets
‪-13.25%‬
Return on Equity
‪-38.99%‬
Ownership
Shares Outstanding
399.00M
Float
372.18M
Held by Insiders
‪7.32%‬
Held by Institutions
‪80.46%‬
Price stats
Beta
‪1.10‬
50-Day Avg
‪96.68‬
200-Day Avg
‪56.46‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 0QF - Moderna Inc.
Peers - 0QF - Moderna Inc.
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
Profile Summary - 0QF - Moderna Inc.
About
Moderna Inc. is a biotechnology company focused on developing medicines and vaccines based on messenger RNA (mRNA) technology. Its commercial portfolio includes respiratory and infectious disease vaccines, while its broader pipeline spans oncology, rare diseases, autoimmune conditions, and other therapeutic areas.…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
